We really need to focus on how we address diseases that affect the entire global community. Ebola, as a disease, while still in Africa is certainly something that can affect other communities across the globe. Right now, many treatment strategies are still sitting on the shelf... We all understand the risks of developing new medicines, but when big pharma cannot find a business case to get behind something like this, we all have a problem. Let's start a new hashtag #globalconscience4Africa 

Nature put out an interesting article on technologies sitting on the shelf that could address infectious diseases in general...  When will enough people globally or at least in developed countries die from Ebola so that making a vaccine for it becomes profitable to big pharma given the significant investment required in research and development on the front end? The economic factors driving the lack of efforts have not been sufficiently discussed in mainstream media. The focus has been more on whether and how it might spread. Public pressure on big pharma is non-existent because we view this as an African disease and therefore not important. We accept that there is no cure but don't discuss the politics and economics of vaccine development. African lives at stake, the potential global spread of the disease, and the incredibly high mortality rate make finding a treatment/cure paramount.

A live updated feed on Ebola

Ebola virus outbreak: live - Telegraph